Sign in

CIK 0001000694

  • Large accelerated filer

NOVAVAX INC

Sign in to watch
Ticker
NVAX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
222816046
Phone
+1 240-268-2000
Business address
21 FIRSTFIELD RD, GAITHERSBURG, MD
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2021-02-16 Glenn Gregory M President, R&D Sale −156 $280.71 $44K 7,125
2021-02-16 Glenn Gregory M President, R&D Sale −522 $281.64 $147K 6,603
2021-02-16 Glenn Gregory M President, R&D Sale −653 $282.13 $184K 5,950
2021-02-16 Glenn Gregory M President, R&D Sale −955 $283.43 $271K 4,995
2021-02-16 Glenn Gregory M President, R&D Sale −1,204 $284.25 $342K 3,791
2021-02-16 Glenn Gregory M President, R&D Sale −59 $285.30 $17K 3,732
2021-02-16 Glenn Gregory M President, R&D Sale −148 $286.26 $42K 3,584
2021-02-16 Glenn Gregory M President, R&D Sale −147 $287.41 $42K 3,437
2021-02-16 Glenn Gregory M President, R&D Sale −9 $288.80 $3K 3,428
2021-02-16 Glenn Gregory M President, R&D Sale −125 $289.89 $36K 3,303
2021-02-16 Glenn Gregory M President, R&D Sale −413 $291.57 $120K 2,890
2021-02-16 Glenn Gregory M President, R&D Sale −13 $294.05 $4K 2,877
2021-02-16 Glenn Gregory M President, R&D Sale −66 $296.58 $20K 2,811
2021-02-16 Glenn Gregory M President, R&D Exercise or conversion +4,819 $5.95 $29K 7,630
2021-02-16 Glenn Gregory M President, R&D Returned to the company −110 $262.70 $29K 7,520
2021-02-16 Glenn Gregory M President, R&D Shares withheld for taxes −2,275 $262.70 $598K 5,245
2021-02-16 Glenn Gregory M President, R&D Exercise or conversion · Stock Option (Right to Buy) −619 2,480
2021-02-16 Glenn Gregory M President, R&D Exercise or conversion · Stock Option (Right to Buy) −868 7,473
2021-02-16 Glenn Gregory M President, R&D Exercise or conversion · Stock Option (Right to Buy) −1,101 17,423
2021-02-16 Glenn Gregory M President, R&D Exercise or conversion · Stock Option (Right to Buy) −3,124 71,876

Page 70 of 87 · 1,734 trades